PDA Technical Report No. 82 (TR 82) is a critical industry document titled . Published by the Parenteral Drug Association, it provides a comprehensive framework for understanding, investigating, and managing the masked endotoxin phenomenon in biopharmaceutical formulations. ⚡ Quick Summary of TR 82
The PDF guide is structured to take a lab from initial discovery to a validated regulatory strategy.
Detailed protocols on how to spike samples and at what intervals to test them to ensure stability. pda technical report 82 pdf
If LER is found, develop a robust demasking protocol that can be consistently replicated in QC.
Clarifies the difference between LER and traditional "Inhibition or Enhancement." PDA Technical Report No
Use "Natural Endotoxin" (NOE) vs. "Control Standard Endotoxin" (CSE) based on the report’s recommendations.
Storage conditions can influence the rate of recovery loss. ### Key Sections of Technical Report 82 ⚡ Quick Summary of TR 82 The PDF
FDA and EMA inspectors frequently cite TR 82 as the "gold standard" for evaluating whether a manufacturer has adequately addressed endotoxin masking. If your product contains polysorbates and a buffer, regulators expect to see an as part of your Biologics License Application (BLA).